Transaortic transcatheter aortic valve implantation using SAPIEN XT or SAPIEN 3 valves in the ROUTE registry†
| Autor: | Martin Thoenes, Dariusz Jagielak, Matthias Thielmann, Peter Bramlage, Mauro Romano, Hardy Baumbach, Nikolaos Bonaros, Cornelia Deutsch, Walter B. Eichinger, Joel Lapeze, Kjell Arne Rein, Marco Aiello, Derk Frank, Mika Laine, Jean Philippe Verhoye, Riccardo Cocchieri, Sidney Chocron, Vinayak Bapat, Douglas F Muir, Gino Gerosa, Louis Labrousse |
|---|---|
| Přispěvatelé: | ACS - Pulmonary hypertension & thrombosis, Cardiothoracic Surgery |
| Rok vydání: | 2017 |
| Předmět: |
Male
Pulmonary and Respiratory Medicine medicine.medical_specialty Transcatheter aortic Medizin 030204 cardiovascular system & hematology Prosthesis Design Severity of Illness Index Transcatheter Aortic Valve Replacement 03 medical and health sciences Postoperative Complications 0302 clinical medicine Internal medicine medicine Humans Prospective Studies Registries Heart valve Cardiovascular mortality Aged 80 and over business.industry Calcinosis Aortic Valve Stenosis medicine.disease Current analysis Europe Survival Rate Stenosis Treatment Outcome medicine.anatomical_structure 030228 respiratory system Aortic Valve Heart Valve Prosthesis Balloon dilation Cardiology Female Surgery Cardiology and Cardiovascular Medicine Complication business Edwards sapien |
| Zdroj: | Interactive cardiovascular and thoracic surgery, 25(5), 757-764. Oxford University Press |
| ISSN: | 1569-9285 1569-9293 |
| DOI: | 10.1093/icvts/ivx159 |
| Popis: | OBJECTIVES Transaortic (TAo) access for transcatheter aortic valve implantation (TAVI) is an alternative to the conventional transfemoral or transapical routes. Data comparing the characteristics and outcomes of TAo-TAVI using the SAPIEN XT and SAPIEN 3 heart valves are scarce. The objective of the current analysis was to provide such information. METHODS ROUTE is an international, prospective, observational registry. Patients with severe calcific aortic stenosis scheduled for TAo-TAVI with an Edwards SAPIEN XT or a SAPIEN 3 heart valve were consecutively enrolled at 22 centres across Europe between February 2013 and February 2015. Periprocedural, in-hospital and 30-day complication rates were assessed. RESULTS Of the 301 patients included, 126 (41.9%) received a SAPIEN 3 and 175 (58.1%) a SAPIEN XT. The SAPIEN 3 was associated with shorter procedure time (101 ± 35 vs 111 ± 40 min; P = 0.031) and a lower quantity of contrast agent used (87 ± 43 vs 112 ± 50 ml; P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|